- $97.66m
- $160.77m
- $313.17m
- 74
- 86
- 69
- 90
Annual income statement for BGSF, fiscal year end - January 1st, USD millions except per share, conversion factor applied.
R2019 December 29th | R2020 December 27th | 2021 December 26th | 2023 December 31st | 2023 January 1st | |
|---|---|---|---|---|---|
| Period Length: | 52 W | 52 W | 52 W | 52 W | 53 W |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 220 | 207 | 239 | 313 | 298 |
| Cost of Revenue | |||||
| Gross Profit | 69.8 | 66 | 80.9 | 112 | 104 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 205 | 208 | 224 | 320 | 282 |
| Operating Profit | 14.3 | -1.23 | 14.5 | -7.18 | 16.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 12.8 | -2.81 | 13.1 | -13.2 | 14.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 9.64 | -2.07 | 10.5 | -10.2 | 11.3 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 13.2 | 1.44 | 14.1 | -10.2 | 25.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 13.2 | 1.44 | 14.1 | -10.2 | 25.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1 | 0.294 | 0.857 | 0.47 | 1.09 |
| Dividends per Share |